When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Hikma Pharmaceuticals ([[HKMPF]] -2.1%) has signed an exclusive license and distribution agreement with AFT Pharmaceuticals for the commercialisation of Combogesic IV, an intravenous, opioid free post-operative pain relief medicine.The licensing agreement provides Hikma with exclusive rights for the sales, marketing and distribution of Combogesic IV in the US.AFT expects to file for approval with the U.S. FDA in the coming months.